Biotech
Guardant Health
Guardant Health raises $360M Series E at $2.15B valuation
Redwood City, CAMay 31, 20181 min read
Total Raised
$360M
Valuation
$2.15B
Latest Round
Series E
Employees
1000+
Guardant Health: Series E Funding Round
Guardant Health has successfully raised $360M in Series E funding, reaching a valuation of $2.15B.
Company Overview
Blood-based cancer detection and monitoring
Funding Details
The Series E round was led by SoftBank Vision Fund, with participation from OrbiMed.
Company Information
- Headquarters: Redwood City, CA
- Founded: 2012
- Employees: 1000+
- Category: Biotech
Investment
Guardant Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- SoftBank Vision Fund: Verified investor in Series E
- OrbiMed: Verified investor in Series E
Company Info
Headquarters
Redwood City, CA
Founded
2012
Team Size
1000+
Last Round
$360M(May 2018)
Investors (2)
S
SoftBank Vision FundLeadLead Investor
Verified investor in Series E
O
OrbiMedInvestor
Verified investor in Series E
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free